- Home
- BOX vs ARQT Comparison
BOX vs ARQT Comparison
Compare BOX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOX | ARQT |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BOX | ARQT |
|---|---|---|
| Price | $23.55 | $25.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $38.00 | $32.14 |
| AVG Volume (30 Days) | ★ 2.4M | 1.2M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.99 | 88.79 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $506,142,000.00 | $376,072,000.00 |
| Revenue This Year | $9.07 | $26.91 |
| Revenue Next Year | $7.74 | $30.59 |
| P/E Ratio | $194.92 | ★ N/A |
| Revenue Growth | 26.98 | ★ 91.34 |
| 52 Week Low | $21.61 | $11.86 |
| 52 Week High | $38.80 | $31.77 |
Technical Indicators
Market Signals| Indicator | BOX | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 42.02 |
| Support Level | $21.61 | $24.81 |
| Resistance Level | $33.30 | $27.26 |
| Average True Range (ATR) | 0.86 | 1.52 |
| MACD | 0.24 | -0.00 |
| Stochastic Oscillator | 61.08 | 7.59 |
Price Performance
Historical ComparisonAbout BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.